• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蓝舌病病毒一种衣壳蛋白的分离,该蛋白可在绵羊体内诱导保护性免疫反应。

Isolation of a capsid protein of bluetongue virus that induces a protective immune response in sheep.

作者信息

Huismans H, van der Walt N T, Cloete M, Erasmus B J

出版信息

Virology. 1987 Mar;157(1):172-9. doi: 10.1016/0042-6822(87)90326-6.

DOI:10.1016/0042-6822(87)90326-6
PMID:3029956
Abstract

A method to purify the neutralization specific antigen of bluetongue virus P2 in large amounts has been developed. The purified protein is free from virus-specified or cellular contaminants and its immunological specificity has been preserved. The purification is based on the observation that protein P2 can be dissociated from the virion by treatment with monovalent or divalent salts. The salt concentration required to solubilize the outer capsid proteins is pH dependent and in general decreases with a decrease in pH. P2 purified by extraction from polyacrylamide gels does not induce immune-precipitating or neutralizing antibodies. The response against P5, on the other hand, is much less conformational dependent and P5 purified from gels readily induces P5-precipitating antibodies in rabbits. These antibodies do not neutralize the virus. Purified P2, immunoabsorbed with anticore serum to remove trace amounts of P7, was injected into sheep. An initial dose of 50 micrograms of P2 was sufficient to induce P2-precipitating antibodies as well as neutralizing and hemagglutination-inhibiting antibodies. These sheep were fully protected against challenge with a virulent strain of the same BTV serotype. Lower doses of P2 still provided a significant level of protection even though no neutralizing antibodies could be detected.

摘要

已开发出一种大量纯化蓝舌病毒P2中和特异性抗原的方法。纯化后的蛋白质不含病毒特异性或细胞污染物,且保留了其免疫特异性。该纯化方法基于这样的观察结果:通过用单价或二价盐处理,蛋白质P2可从病毒粒子中解离出来。溶解外膜蛋白所需的盐浓度取决于pH值,一般随pH值降低而降低。从聚丙烯酰胺凝胶中提取纯化的P2不会诱导免疫沉淀或中和抗体。另一方面,针对P5的反应对构象的依赖性要小得多,从凝胶中纯化的P5很容易在兔体内诱导出P5沉淀抗体。这些抗体不能中和病毒。用抗核心血清免疫吸附以去除痕量P7的纯化P2被注射到绵羊体内。50微克的初始剂量P2足以诱导出P2沉淀抗体以及中和抗体和血凝抑制抗体。这些绵羊对同一蓝舌病毒血清型的强毒株攻击具有完全的抵抗力。即使检测不到中和抗体,较低剂量的P2仍能提供显著水平的保护。

相似文献

1
Isolation of a capsid protein of bluetongue virus that induces a protective immune response in sheep.蓝舌病病毒一种衣壳蛋白的分离,该蛋白可在绵羊体内诱导保护性免疫反应。
Virology. 1987 Mar;157(1):172-9. doi: 10.1016/0042-6822(87)90326-6.
2
Identification of the serotype-specific and group-specific antigens of bluetongue virus.蓝舌病病毒血清型特异性和群特异性抗原的鉴定
Onderstepoort J Vet Res. 1981 Jun;48(2):51-8.
3
Analysis of the roles of bluetongue virus outer capsid proteins VP2 and VP5 in determination of virus serotype.蓝舌病病毒外衣壳蛋白VP2和VP5在病毒血清型确定中的作用分析
Virology. 1989 Jun;170(2):561-5. doi: 10.1016/0042-6822(89)90447-9.
4
Recombinant virus vaccine for bluetongue disease in sheep.绵羊蓝舌病重组病毒疫苗
J Virol. 1990 May;64(5):1998-2003. doi: 10.1128/JVI.64.5.1998-2003.1990.
5
Immunologic response of sheep to inactivated and virulent bluetongue virus.绵羊对灭活和强毒蓝舌病病毒的免疫反应。
Am J Vet Res. 1985 May;46(5):1043-9.
6
Protective efficacy of Bluetongue virus-like and subvirus-like particles in sheep: presence of the serotype-specific VP2, independent of its geographic lineage, is essential for protection.绵羊蓝舌病病毒样和类病毒样颗粒的保护效力:血清型特异性 VP2 的存在(与其地理谱系无关)对保护至关重要。
Vaccine. 2012 Mar 9;30(12):2131-9. doi: 10.1016/j.vaccine.2012.01.042. Epub 2012 Jan 26.
7
Potency and efficacy of inactivated bluetongue virus vaccines.
Prog Clin Biol Res. 1985;178:649-52.
8
In vitro neutralization of antigenic variants of bluetongue virus is related to in vivo protection.
Viral Immunol. 1989 Fall;2(3):195-203. doi: 10.1089/vim.1989.2.195.
9
Temporal development of bluetongue virus protein-specific antibody in sheep following natural infection.自然感染后绵羊体内蓝舌病病毒蛋白特异性抗体的时间动态变化。
Vet Microbiol. 1988 Mar;16(3):231-41. doi: 10.1016/0378-1135(88)90027-2.
10
Conformationally dependent epitopes of bluetongue virus neutralizing antigen.蓝舌病病毒中和抗原的构象依赖性表位
Viral Immunol. 1989;2(1):17-24. doi: 10.1089/vim.1989.2.17.

引用本文的文献

1
Plasmid DNA-based reverse genetics as a platform for manufacturing of bluetongue vaccine.基于质粒DNA的反向遗传学作为蓝舌病疫苗生产平台。
J Virol. 2025 Apr 15;99(4):e0013925. doi: 10.1128/jvi.00139-25. Epub 2025 Mar 6.
2
Evaluating Temperature Effects on Bluetongue Virus Serotype 10 and 17 Coinfection in .评估温度对 10 型和 17 型蓝舌病毒混合感染的影响。
Int J Mol Sci. 2024 Mar 6;25(5):3063. doi: 10.3390/ijms25053063.
3
In Situ Hybridization (RNAscope) Detection of Bluetongue Virus Serotypes 10 and 17 in Experimentally Co-Infected .
实验性共同感染中蓝舌病毒10型和17型的原位杂交(RNAscope)检测
Pathogens. 2023 Sep 30;12(10):1207. doi: 10.3390/pathogens12101207.
4
Increased Clinical Signs and Mortality in IFNAR Mice Immunised with the Bluetongue Virus Outer-Capsid Proteins VP2 or VP5, after Challenge with an Attenuated Heterologous Serotype.用蓝舌病毒外膜蛋白VP2或VP5免疫的IFNAR小鼠,在用减毒异源血清型病毒攻击后,临床症状加重且死亡率增加。
Pathogens. 2023 Apr 15;12(4):602. doi: 10.3390/pathogens12040602.
5
The Combined Expression of the Nonstructural Protein NS1 and the N-Terminal Half of NS2 (NS2) by ChAdOx1 and MVA Confers Protection against Clinical Disease in Sheep upon Bluetongue Virus Challenge.ChAdOx1 和 MVA 联合表达非结构蛋白 NS1 和 NS2 的 N 端半段(NS2)可预防绵羊在蓝舌病病毒攻毒后发生临床疾病。
J Virol. 2022 Feb 9;96(3):e0161421. doi: 10.1128/JVI.01614-21. Epub 2021 Nov 17.
6
The Interplay between Bluetongue Virus Infections and Adaptive Immunity.蓝舌病病毒感染与适应性免疫的相互作用。
Viruses. 2021 Jul 31;13(8):1511. doi: 10.3390/v13081511.
7
Production and Easy One-Step Purification of Bluetongue Recombinant VP7 from Infected Sf9 Supernatant for an Immunoenzymatic Assay (ELISA).蓝舌病重组 VP7 的从感染 Sf9 上清液的生产和简易一步纯化及其用于免疫酶测定(ELISA)。
Mol Biotechnol. 2021 Jan;63(1):40-52. doi: 10.1007/s12033-020-00282-8. Epub 2020 Oct 19.
8
Implications of a conserved region of bluetongue virus protein VP2 in cross-neutralisation of bluetongue virus serotypes.蓝舌病病毒蛋白 VP2 的保守区域对蓝舌病病毒血清型交叉中和的影响。
Onderstepoort J Vet Res. 2020 Oct 8;87(1):e1-e6. doi: 10.4102/ojvr.v87i1.1816.
9
A protective bivalent vaccine against Rift Valley fever and bluetongue.一种针对裂谷热和蓝舌病的二价保护性疫苗。
NPJ Vaccines. 2020 Jul 30;5(1):70. doi: 10.1038/s41541-020-00218-y. eCollection 2020.
10
Ecological Dynamics Impacting Bluetongue Virus Transmission in North America.影响北美洲蓝舌病病毒传播的生态动力学
Front Vet Sci. 2020 Apr 17;7:186. doi: 10.3389/fvets.2020.00186. eCollection 2020.